NEW YORK, April 24 - Iceland Genomics said today that its scientists had identified through the Iceland Cancer Project several chromosomal loci for genes related to an increase risk of breast, prostate, and other cancers.
The project, which aims to identify novel cancer genes, is a collaboration of the Reykjavik-based company and the Iceland Cancer Clinicians group as well as the Icelandic Cancer Society and the two main hospitals in
The company, with the help of its collaborators, is performing a population-wide association study with 2,500 cancer patients and 1,500 healthy controls. They have mapped five loci in which genetic variations contribute to an increased risk of cancer, the company said, and are now planning to validate their results in other populations and isolate the specific genes.
"It has been known for a long time that
The company plans to use its discoveries to market diagnostic tests and services, and to market its database for drug target discovery.